PDL-1 Positive

1 clinical trials · Condition

Record	Firm	Date
Phase II Trial Evaluating the Safety and Efficacy of the Combination of Zimberelimab, Domvanalimab and Sacituzumab Govitecan as 1L Therapy for PD-L1 Positive Advanced TNBC (NCT07134556)	MedSIR	2026-04-01

Every clearance here is in the API, with alerts when new ones post.